Overview

Glucocorticosteroid Therapy on Drug-induced Liver Injury: a Prospective Non-randomized Concurrent Control Trial

Status:
Recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of glucocorticosteroid for treatment of drug-induced liver injury.
Phase:
Phase 4
Details
Lead Sponsor:
Li Yang
Treatments:
Choline
Glucocorticoids
Methylprednisolone
Polyene phosphatidylcholine
Prednisone